These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 3844820)
21. Correlation between mixed lymphocyte cultures and anti-Epstein Barr virus (EBV) antibodies in Hodgkin's disease and non Hodgkin lymphoma patients. Sasiain MC; Fejes M; Ares BR; Brezavscek D; Bachmann AE Biomedicine; 1981 Oct; 35(5):153-6. PubMed ID: 6274439 [TBL] [Abstract][Full Text] [Related]
22. Correlation of high numbers of intratumoral FOXP3+ regulatory T cells with improved survival in germinal center-like diffuse large B-cell lymphoma, follicular lymphoma and classical Hodgkin's lymphoma. Tzankov A; Meier C; Hirschmann P; Went P; Pileri SA; Dirnhofer S Haematologica; 2008 Feb; 93(2):193-200. PubMed ID: 18223287 [TBL] [Abstract][Full Text] [Related]
23. [Lymphoid depletion type 4 Hodgkin disease. Anatomoclinical review of 35 cases]. Eghbali H; Pétorin C; de Mascarel I; Trojani M; Hoerni-Simon G; Soubeyran P; Hoerni B Bull Cancer; 1994 Oct; 81(10):866-70. PubMed ID: 7734769 [TBL] [Abstract][Full Text] [Related]
24. Non-Hodgkin's lymphomas. analysis of 109 Japanese cases with the use of LSGJ classification. Shimizu M; Miura M; Kitahara M; Katayama I Am J Pathol; 1982 Jan; 106(1):30-9. PubMed ID: 7034544 [TBL] [Abstract][Full Text] [Related]
25. Malignant lymphomas in Korea. Chi JG; Shin SS; Ahn GH; Lee SK Jpn J Clin Oncol; 1985 Dec; 15(4):653-9. PubMed ID: 4094098 [TBL] [Abstract][Full Text] [Related]
26. An EBMT registry matched study of allogeneic stem cell transplants for lymphoma: allogeneic transplantation is associated with a lower relapse rate but a higher procedure-related mortality rate than autologous transplantation. Peniket AJ; Ruiz de Elvira MC; Taghipour G; Cordonnier C; Gluckman E; de Witte T; Santini G; Blaise D; Greinix H; Ferrant A; Cornelissen J; Schmitz N; Goldstone AH; Bone Marrow Transplant; 2003 Apr; 31(8):667-78. PubMed ID: 12692607 [TBL] [Abstract][Full Text] [Related]
28. Childhood social environment and Hodgkin's lymphoma: new findings from a population-based case-control study. Chang ET; Zheng T; Weir EG; Borowitz M; Mann RB; Spiegelman D; Mueller NE Cancer Epidemiol Biomarkers Prev; 2004 Aug; 13(8):1361-70. PubMed ID: 15298959 [TBL] [Abstract][Full Text] [Related]
29. How to differentiate between T-cell-rich B-cell lymphoma and lymphocyte-predominant Hodgkin's disease. Evidence for the value of MB1 and 4KB5 immunostaining. Schmidt U; Herbst J; Metz KA; Leder LD J Pathol; 1996 Jun; 179(2):138-44. PubMed ID: 8758204 [TBL] [Abstract][Full Text] [Related]
30. [Paraneoplastic lymphadenopathy]. Melikian AL; Nikitin EA; Kaplanskaia IB; Frank GA Ter Arkh; 2007; 79(8):44-52. PubMed ID: 17926471 [TBL] [Abstract][Full Text] [Related]
31. Expression of CD95 antigen and Bcl-2 protein in non-Hodgkin's lymphomas and Hodgkin's disease. Nguyen PL; Harris NL; Ritz J; Robertson MJ Am J Pathol; 1996 Mar; 148(3):847-53. PubMed ID: 8774139 [TBL] [Abstract][Full Text] [Related]
32. Characterization and expression of CT45 in Hodgkin's lymphoma. Heidebrecht HJ; Claviez A; Kruse ML; Pollmann M; Buck F; Harder S; Tiemann M; Dörffel W; Parwaresch R Clin Cancer Res; 2006 Aug; 12(16):4804-11. PubMed ID: 16914565 [TBL] [Abstract][Full Text] [Related]
33. [Non Hodgkin's and Hodgkin's lymphomas and HIV: frequency, outcome and immune response under HAART; Clermont-Ferrand University Hospital, 1991-2003]. Jacomet C; Lesens O; Villemagne B; Darcha C; Tournilhac O; Henquell C; Cormerais L; Gourdon F; Peigue-Lafeuille H; Travade P; Beytout J; Laurichesse H Med Mal Infect; 2006 Mar; 36(3):157-62. PubMed ID: 16503104 [TBL] [Abstract][Full Text] [Related]
34. Rheumatic manifestations at presentation of Hodgkin's disease and non-Hodgkin's malignant lymphoma. A national survey of one hundred forty-six patients. Gaudin P; Rozand Y; Fauconnier J; Phelip X Rev Rhum Engl Ed; 1995 May; 62(5):365-75. PubMed ID: 7655870 [TBL] [Abstract][Full Text] [Related]
35. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue. Hagemeister FB Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984 [TBL] [Abstract][Full Text] [Related]
36. [Possible interactions between Toxoplasma gondii infection and the presence of non-Hodgkin's lymphoma]. Ortiz-Muñoz AB; Cuadrado-Méndez L; Sanchis-Belenguer R Rev Esp Oncol; 1984; 31(2):237-45. PubMed ID: 6400214 [TBL] [Abstract][Full Text] [Related]
37. [Hemolytic anemia due to cold-reacting antibodies: association with human immunodeficiency virus infection and non-Hodgkin's lymphoma]. López Dupla JM; Rodríguez Pérez A; Martínez Martínez P; de Castro Carpeño J; Lavilla Uriol P; Gil Aguado A Med Clin (Barc); 1992 Apr; 98(13):502-4. PubMed ID: 1583950 [TBL] [Abstract][Full Text] [Related]
38. Epstein-Barr virus detection in non-Hodgkin's lymphoma of the oral cavity: an immunocytochemical and in situ hybridization study. Leong IT; Fernandes BJ; Mock D Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Aug; 92(2):184-93. PubMed ID: 11505266 [TBL] [Abstract][Full Text] [Related]
39. [Elevated Epstein-Barr virus antibodies in patients with Hodgkin's disease]. Kuljić-Kapulica N Srp Arh Celok Lek; 1998; 126(3-4):97-100. PubMed ID: 9863363 [TBL] [Abstract][Full Text] [Related]
40. Immunological characterization of Hodgkin's and non-Hodgkin's lymphoma patients with high antibody titers against Epstein-Barr virus-associated antigens. Masucci G; Mellstedt H; Masucci MG; Szigeti R; Ernberg I; Björkholm M; Tsukuda K; Henle G; Henle W; Pearson G Cancer Res; 1984 Mar; 44(3):1288-300. PubMed ID: 6318984 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]